Skip to content

Released Aug 5, 2010, after the close

10-Q filed Aug 5, 2010, 36 days after period end · 0000950123-10-073394

Q2 2010 · 10-Q
Revenue$1.14Mno prior Q2 2009 on file
Net Income-$10.04Mno prior Q2 2009 on file
EPS Diluted$0.12no prior Q2 2009 on file
Gross Profit$613,000—
Operating Income-$10,150,000—
Margins · derived
Gross margin53.7%
Operating margin-889.6%
Net margin-880.0%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR